 |
A newsletter for those involved in clinical trials. Published 20 times a
year by Canary LtdFinancial disclosure
The following articles on this topic have been published in
CRAdvisor (CRA) – the year, issue number
and starting page number for each are listed below:
Back to index |
|
2006 |
|
| CRA 2006; 182:4 |
Conflicts of interest need evaluating for every trial. |
| CRA 2006; 182:11 |
Former FDA Commissioner pleads guilty to financial
conflict of interest. |
|
|
|
|
2005 |
|
|
CRA 2005; 147:6 |
NIH announces ethics reform. |
|
CRA 2005; 157:6 |
US National Institutes of Health issues final ethics rule. |
| CRA 2005; 158:3 |
Sponsors fail to meet regulatory obligations. |
|
|
|
|
2004 |
|
|
CRA 2004; 126:7 |
Call for standardisation of conflict of interest. |
|
CRA 2004; 127:1 |
After revelations over MMR
research, should academic trials be exempt from new European legislation? |
|
CRA 2004; 128:6 |
US investigators found to have
financial conflicts of interest too! |
|
CRA 2004; 132:3 |
Lessons to learn as jury clears
cancer centre. |
|
CRA 2004; 132:3 |
New guidance to protect trial
subjects from financial conflicts of interest. |
|
CRA 2004; 139:6 |
Can the NIH manage its conflicts
of interest? |
|
CRA 2004; 140:7 |
NIH bans collaboration with
companies. |
|
|
|
|
2003 |
|
|
CRA 2003; 112:4 |
New guidance for financial conflicts of interest. |
|
CRA 2003; 122:8 |
Major journals forced to consider conflict of interest
policy. |
|
|
|
|
2002 |
|
|
CRA 2002; 81:1 |
Plans for more thorough monitoring of financial
disclosure. |
|
CRA 2002; 84:5 |
FDA proposes new guidance for financial disclosure by
advisory committee members. |
|
CRA 2002; 100:6 |
An overview of US regulations contained in the Code of
Federal Regulations. |
|
|
|
|
2001 |
|
|
CRA 2001; 67:1 |
FDA issues new guidance on financial disclosure. |
|
CRA 2001; 67:6 |
Consent forms and financial disclosure. |
|
CRA 2001; 68:6 |
Financial disclosure guidance. |
|
CRA 2001; 69:1 |
New guidance on financial disclosure issued by the FDA. |
|
CRA 2001; 69:2 |
Summary of the 2001 Guidance on Financial Disclosure. |
|
|
|
|
2000 |
|
|
CRA 2000; 59:1 |
FDA yet to issue new guidance on
financial disclosure. |
|
CRA 2000; 59:1 |
Model policy for financial disclosure? |
|
|
|
|
1999 |
|
|
CRA 1999; 26:1 |
FDA financial disclosure rules now in effect. |
|
CRA 1999; 38:6 |
Financial disclosure help. |
|
CRA 1999; 39:s |
Financial disclosure by clinical
investigators guidance for industry. |